A 54-Year-Old Woman with Donor Cell Origin of Multiple Myeloma after Allogeneic Hematopoietic Stem Cell Transplantation for the Treatment of CML
Chronic myeloid leukemia is a myeloproliferative disorder that may be treated with hematopoietic stem cell transplantation (HSCT). While posttransplantation relapse of disease resulting from a failure to eradicate the patient’s original leukemia could occur, patients may also rarely develop a second...
Saved in:
Main Authors: | Erika Maestas, Shikha Jain, Patrick Stiff |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2016-01-01
|
Series: | Case Reports in Hematology |
Online Access: | http://dx.doi.org/10.1155/2016/6751914 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Endocrinopathies after Allogeneic and Autologous Transplantation of Hematopoietic Stem Cells
by: Francesco Orio, et al.
Published: (2014-01-01) -
Limbic Encephalitis following Allogeneic Hematopoietic Stem Cell Transplantation
by: Silje Johansen, et al.
Published: (2022-01-01) -
Isatuximab for Delayed Red Cell Engraftment after Allogeneic Hematopoietic Cell Transplantation
by: Mary Nauffal, et al.
Published: (2024-01-01) -
Advances in allogeneic hematopoietic stem cell transplantation for Langerhans cell histiocytosis in children
by: Guangqiang Meng, et al.
Published: (2025-01-01) -
UPDATE ON CYTOMEGALOVIRUS INFECTION MANAGEMENT IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS
by: José Luis Piñana, et al.
Published: (2024-08-01)